失禁デバイスの世界市場-2023-2030

市場概要

失禁デバイスの市場規模は、予測期間（2023～2030年）にCAGR6.4%で成長するとされています。

失禁とは、膀胱からの不随意の排尿（尿失禁）、または排便（便失禁） を指します。尿失禁は、世界中で2億人が罹患している広範な医学的疾患です。尿失禁は、女性では男性の2倍の頻度で発生しています。

市場力学

失禁デバイスの世界市場を牽引する主な要因は、過活動膀胱や腎臓結石などの慢性疾患の世界の増加、研究開発費の増加、高齢者人口の急増です。新規製品の上市が増加したことが、失禁治療器市場の成長に寄与しました。

慢性疾患に伴う失禁の増加や技術的に進んだ製品の発売が、市場の成長を後押しするものと思われます。

これらの失禁デバイス製品に関する研究の高まりや、老人人口における過活動膀胱などの膀胱疾患の有病率の増加が、市場成長の原動力となります。また、世界の慢性疾患の増加も市場の成長を後押ししています。米国疾病対策予防センター（CDC）によると、慢性腎臓病（CKD）は45～64歳（13%）、18～44歳（7%）よりも65歳以上（38%）でより一般的になっています。多くのヘルスケア企業が、斬新で革新的、かつ技術的に高度な製品を開発するために、研究開発活動を活発化させています。

市場の成長を後押しする主な要因としては、泌尿器科疾患に苦しむ高齢者人口の増加、腎臓結石などの慢性疾患に伴う失禁の増加、革新的なデバイスの利用可能性などが挙げられます。さらに、新規製品の研究開発の増加や、主要メーカーによる技術的に高度な製品の提供も、市場の成長に重要な役割を果たすと予想されます。

様々な新規製品の発売、規制当局の承認、調査研究は、市場の成長に寄与しています。例えば、2021年11月10日、ストレス性尿失禁治療および骨盤臓器脱の手術製品を開発する医療機器企業であるカルデラメディカルは、ストレス性尿失禁を治療するための新規製品「デサラTVez」の認可を発表しています。今回の発売により、ストレス性尿失禁の治療オプションに悩む女性のために、クラデラの最も幅広い製品ポートフォリオがさらに充実することになります。

失禁手術に伴うリスクは、市場の成長を妨げると予想されます。

しかし、失禁手術に伴うリスクには、一時的な排尿困難、尿路感染、過活動膀胱の発症、鼠径部の痛み、膣内への手術材料の突出などがあります。これらの要因が市場成長の妨げとなる可能性があります。

また、認知度の低さも市場の成長を抑制する主要因となっています。低所得国では、人々は失禁デバイスの使用について認識しておらず、償還シナリオが利用できないことが市場の成長を阻害しています。

COVID-19の影響分析

パンデミックは、世界の財政的な期待、オペレーション、危機対応戦略にプラスの影響を与えています。COVID-19の発生は、ヘルスケア産業に深刻な影響を与えました。過活動膀胱治療市場は、コビドにより莫大な利益を経験しました。コビド患者では、過活動膀胱などの膀胱に関連する問題も観察されました。コビッドは患者の膀胱に影響を及ぼしました。主要メーカーは、様々な研究および臨床試験を開始しました。様々な取り組み、製品の上市、コラボレーション、合併が世界中で行われており、市場の成長を後押ししています。例えば、2022年7月、ウロバント・サイエンス社は、欧州エリアにおける過活動膀胱治療のためのVibegronの商業化に関するピエールファーブル・メディカメント社とのライセンス契約を発表しました。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 市場影響要因
  • 促進要因
    • 慢性疾患に伴う失禁の増加
    • 技術的に高度な製品の上市の増加
  • 抑制要因
    • 失禁手術に伴うリスク
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• プライシング分析

第6章 COVID-19の分析

• COVID-19の市場分析
  • COVID-19以前の市場シナリオ
  • COVID-19の現在の市場シナリオ
  • COVID-19の後、または将来のシナリオ
• COVID-19の中での価格ダイナミクス
• 需要-供給スペクトラム
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的取り組み
• まとめ

第7章 製品タイプ別

• 尿道カテーテル
  • フォーリーカテーテル
  • その他尿道カテーテル
• 電気刺激装置
• 膣スリング
  • 従来の膣スリング
  • アドバンストバジナルスリング
  • ビオチン
  • その他
• 人工尿道括約筋

第8章 カテゴリー別

• 外尿道口失禁治療器
• 内部尿失禁用具

第9章 失禁タイプ別

• ストレス性尿失禁
• 切迫性失禁
• 溢流性失禁
• 機能性失禁

第10章 エンドユーザー別

• 病院
• クリニック
• 在宅医療

第11章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第12章 競合情勢

• 主な展開と戦略
• 企業シェア分析
• 製品ベンチマーク
• 注目の主要企業リスト

第13章 企業プロファイル

• B. Braun Melsungen AG
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• ConvaTec Inc.
• Coloplast Corp
• BD
• Promedon GmbH
• Medtronic Plc
• Wellspect HealthCare（Dentsply Sirona）
• Hollister Incorporated
• A.M.I. GmbH
• Caldera Medical

第14章 失禁デバイスの世界市場-DataM

Market Overview

Incontinence Devices Market size was valued at US$ XX million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 6.4% during the forecast period (2023-2030).

Incontinence refers to involuntary loss of urine from the bladder (urinary incontinence) or bowel motion, feces, or wind from the bowel (fecal or bowel incontinence). Urinary incontinence is a widespread medical condition that affects 200 million people worldwide. Urinary Incontinence is twice as common in women as in men.

Market Dynamics

The major factors driving the global incontinence devices market are an increase in chronic diseases such as overactive bladder or kidney stones globally, rising research and development expenditure and a surge in the geriatric population. An increase in novel product launches contributed to the growth of the incontinence devices market.

Increased incontinence associated with chronic conditions and technologically advanced product launches is expected to drive the market's growth.

The rising research on these incontinence device products and the growth in the prevalence of bladder disorders such as overactive bladder in the geriatric population will drive the market growth. An increase in chronic diseases globally is also aiding market growth. Chronic kidney disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45-64 years (13%) or 18-44 years (7%), according to the Centers for Disease Control and Prevention (CDC). There has been an increase in R&D activities by many healthcare companies to develop novel, innovative and technologically advanced products.

The key factors boosting the market growth include the rise in the geriatric population that suffers from urological conditions, the increase in incontinence associated with chronic conditions such as kidney stones and the availability of innovative devices. Moreover, the increase in research and development of novel products and the availability of technologically advanced products by key players are also expected to play a vital role in the market's growth.

Various novel product launches, regulatory approvals and research studies contribute to the market's growth. For instance, in November 10, 2021, Caldera Medical, a medical device company developing surgical products for stress urinary incontinence treatment and Pelvic Organ Prolapse, announced its clearance for the novel Desara TVez for treating stress urinary incontinence. This launch further expands Cladera's broadest product portfolio for women suffering from stress urinary incontinence treatment options.

The risks associated with incontinence surgery are expected to hamper the market's growth.

However, the risks associated with incontinence surgery include temporary difficulty urinating, urinary tract infection, development of an overactive bladder, groin pain and surgical material sticking out into the vagina. These factors may hinder the growth of the market.

Lack of awareness is also a leading factor restraining the market's growth. In low-income countries, people are unaware of incontinence device usage, and the unavailability of reimbursement scenarios hinders the market's growth.

COVID-19 Impact Analysis

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The overactive bladder treatment market has experienced huge profits due to COVID. In covid patients, bladder-related problems such as overactive bladder were also observed. COVID affected the bladders of patients. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in July 2022, Urovant Sciences announced its license agreement with Pierre Fabre Medicament for Vibegron commercialization for overactive bladder treatment in European Areas.

Segment Analysis

The electrical stimulation devices segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The electrical stimulation devices segment is the highest market holder in the global incontinence devices market. The global incontinence devices market is segmented based on product type as urinary catheters, electrical stimulation devices, vaginal slings, and artificial urinary sphincters. The electrical stimulation device segment is the largest market shareholder due to its high demand, advantages and usage, rising adoption of these incontinence devices, better results in bladder disorder patients and increased research and development activities, which are expected to remain high during the forecast period.

The electrical stimulation device or neurostimulation device utilizes an electrode that is implanted under the skin to stimulate nerves with electricity around the bladder. The electric signals traveling from the bladder to the brain are blocked with electricity reducing the symptoms of an overactive bladder are blocked. These therapies are of two types: sacral neuromodulation and percutaneous tibial nerve stimulation.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in April 2021, Medtronic, the medical technology company, announced receiving approval from the United States Food and Drug Administration to continue the investigational device exemption trial for evaluating its implantable tibial neuromodulation device, an internally developed therapy specially developed for bladder incontinence symptom's relief.

Geographical Analysis

North America holds the largest market share in the global incontinence devices market.

North America dominates the global incontinence devices market, primarily due to its large population, excellent medical infrastructure, and rising number of bladder-related disorders. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure. As per the National Association for Incontinence (NAFC), in North America, nearly 200 million people were affected by urinary incontinence in 2021. According to WomensHealth.gov, urinary incontinence is twice as common in men, whereas stress urinary incontinence is most common in pregnant women, giving birth and going through menopause.

Increasing expenditure on healthcare and raising awareness among people are also contributing to the market's growth in this region. Advancement of products for different types of incontinence, including stress incontinence, urge incontinence, overflow incontinence, functional incontinence, increase in pharmaceutical establishment across the region, government approvals, and key players in the region are contributing to the growth of the incontinence devices market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, regulatory approvals, technological advancements, collaborations, and agreements are taking place in this region. In Oct 2020, Essity health and hygiene company launched TENA SmartCare. It is a novel, reusable digital sensor for better incontinence care. It will be available for working professionals and home caregivers.

Competitive Landscape

The incontinence devices market is moderately competitive with local and global companies' presence. B. Braun Melsungen AG, ConvaTec Inc., Coloplast Corp, BD, Promedon GmbH, Medtronic Plc, Wellspect HealthCare (Dentsply Sirona), Hollister Incorporated, A.M.I. GmbH, Caldera Medical and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in August 11, 2022, A.M.I. GmbH announced its partnership with Medistim Norge AS, an established provider of medical devices for Norwegian health institutions. This collaboration will extend Norge's product portfolio in urogynecology, coloproctology, and urology and will provide products and solutions for incontinence, pelvic organ prolapses and hemorrhoid patients.

B. Braun Melsungen AG.

Overview: B. Braun is a company that manufactures medical and pharmaceuticals device. Headquartered in Melsungen, Germany and founded in 1839. They provide services in around 60 countries that employ around 63,000 people. They have around 5,000 varieties of healthcare products.

Product Portfolio:

Actreen Mini Cath: Actreen Mini Cath is a urinary catheter that is short and specially designed for the self-catheterization of females. It is a modern and feminine design and is ready to use as a catheter.

The global incontinence devices market report would provide access to approx.: 45+ market data tables, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increased incontinence associated with chronic conditions
    • 4.1.1.2. Rising technologically advanced product launches
  • 4.1.2. Restraints:
    • 4.1.2.1. Risks associated with incontinence surgery
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1 Porter's Five Forces Analysis
• 5.2 Supply Chain Analysis
• 5.3 Pricing Analysis

6. COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturer's Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Urinary Catheters *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.2.3. Foley Catheters
  • 7.2.4. Other Urinary Catheters
• 7.3. Electrical Stimulation Devices
• 7.4. Vaginal Slings
  • 7.4.1. Conventional Vaginal Slings
  • 7.4.2. Advanced Vaginal Slings
  • 7.4.3. Biotin
  • 7.4.4. Others
• 7.5. Artificial Urinary Sphincters

8. By Category

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  • 8.1.2. Market Attractiveness Index, By Category
• 8.2. External Urinary Incontinence Devices *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Internal Urinary Incontinence Devices

9. By Incontinence Type

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
  • 9.1.2. Market Attractiveness Index, By Incontinence Type
• 9.2. Stress Incontinence *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 9.3. Urge Incontinence
• 9.4. Overflow Incontinence
• 9.5. Functional Incontinence

10. By End-User

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.1.2. Market Attractiveness Index, By End-User
• 10.2. Hospitals *
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 10.3. Clinics
• 10.4. Homecare

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1. U.S.
    • 11.2.7.2. Canada
    • 11.2.7.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. U.K.
    • 11.3.7.3. France
    • 11.3.7.4. Italy
    • 11.3.7.5. Spain
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan
    • 11.5.7.4. Australia
    • 11.5.7.5. Rest of Asia Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Incontinence Type
  • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

• 12.1. Key Developments and Strategies
• 12.2. Company Share Analysis
• 12.3. Products Benchmarking
• 12.4. List of Key Companies to Watch

13. Company Profiles

• 13.1. B. Braun Melsungen AG *
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Key Highlights
  • 13.1.4. Financial Overview
• 13.2. ConvaTec Inc.
• 13.3. Coloplast Corp
• 13.4. BD
• 13.5. Promedon GmbH
• 13.6. Medtronic Plc
• 13.7. Wellspect HealthCare (Dentsply Sirona)
• 13.8. Hollister Incorporated
• 13.9. A.M.I. GmbH
• 13.10. Caldera Medical

LIST NOT EXHAUSTIVE

14. Global Incontinence Devices Market - DataM

• 14.1. Appendix
• 14.2. About Us and End-User
• 14.3. Contact Us